The disease-modifying effects of hyaluronan in the osteoarthritic disease state
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(22):26 Clin Med Insights Arthritis Musculoskelet Disord. 2017;10:1-10What this means for my practice?
Although there are many molecules that will reduce the pain and inflammation due to OA, HA has the potential to reduce pain as well as to protect and restore the chondral matrix.
Study Summary
This review describes the etiology and pathophysiology of osteoarthritis (OA) and the role of hyaluronan (HA) in its progression. HAs antinociceptive and anti-inflammatory actions and disease modifying effects of the extracellular matrix (ECM) are further explored.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!